Liver Disease Advocates Push for Policy Changes Amidst Underserved Patient Population
Event summary
- The American Liver Foundation (ALF) is hosting a 'Liver Life Advocacy Summit' in Washington, D.C., April 21-22, 2026.
- Advocates will focus on legislative priorities including support for living donors, improved patient access, pediatric screening, and CDC initiatives.
- The summit aims to influence Congress to address the fact that liver disease affects approximately 100 million Americans, but receives comparatively low federal investment.
- ALF will honor Congressman Don Bacon (R-NE) and Congressman Jim Costa (D-CA) for their contributions to liver health advocacy.
The big picture
The ALF's advocacy push highlights a significant gap in federal investment and attention towards liver disease, a condition affecting a substantial portion of the US population. This initiative underscores the growing role of patient advocacy groups in shaping healthcare policy and influencing resource allocation. The focus on issues like living donor support and access to care reflects broader trends toward addressing financial barriers and health equity within the healthcare system.
What we're watching
- Policy Impact
- The success of ALF's lobbying efforts will hinge on bipartisan support, given the current political climate and potential for legislative gridlock.
- Funding Trends
- Increased CDC funding for MASLD surveillance and screening could signal a broader shift in public health priorities, but will depend on budget allocations.
- Patient Engagement
- The long-term sustainability of ALF's advocacy relies on maintaining and expanding its network of 'Liver Life Advocates' and their ability to influence policymakers.
Related topics